Thin Structural Design Concomitating with Greater Deliverability

Ideal Strut Thickness
Racer CC is designed with thinner struts to provide the healing advantage associated with minimal vessel injury and better endothelialisation.
Greater Deliverability
Racer CC with its ideal strut thickness offers optimal strength, flexibility and pushability thus ensuring precise deployment
Enhanced Biocompatibility
The trusted stent platform of Racer CC has been steadily optimized with thinner struts and cell design offering better long-term outcomes

Resources
Product Brochure

In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.

Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.

Unmatched Safety- In Complex Patients Subset

Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from 3 randomised trials.

At 4 years, Biodegradable Polymer DES Yukon showed significantly lower rates of Stent Thrombosis compared to Durable Polymer DES in patients with Diabetes Mellitus.

Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from 3 randomised trials.

At 4 years, Biodegradable Polymer DES Yukon showed significantly lower rates of Stent Thrombosis compared to Durable Polymer DES in patients with Diabetes Mellitus.

Technical Data

PRODUCT MATRIX / ORDERING INFORMATION*

*Please contact our customer care for available sizes

COMPLIANCE CHART

Share